These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17642445)

  • 41. Essential hypertension and the sympathetic nervous system.
    Grassi G; Quarti-Trevano F; Dell'oro R; Mancia G
    Neurol Sci; 2008 May; 29 Suppl 1():S33-6. PubMed ID: 18545892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Optimization of pharmacotherapy in patients with essential hypertension with neurohumoral modulators with consideration of data on heart rate variability].
    Kakhramanova SM; Bakhshaliev AB
    Kardiologiia; 2013; 53(12):25-32. PubMed ID: 24800478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress contributes to renovascular hypertension.
    Oliveira-Sales EB; Dugaich AP; Carillo BA; Abreu NP; Boim MA; Martins PJ; D'Almeida V; Dolnikoff MS; Bergamaschi CT; Campos RR
    Am J Hypertens; 2008 Jan; 21(1):98-104. PubMed ID: 18091751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autonomic nervous system activity during bladder filling assessed by heart rate variability analysis in women with idiopathic overactive bladder syndrome or stress urinary incontinence.
    Hubeaux K; Deffieux X; Ismael SS; Raibaut P; Amarenco G
    J Urol; 2007 Dec; 178(6):2483-7. PubMed ID: 17937953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of hypertension. 3. Antihypertensive agents affecting catecholamine metabolism].
    Faulhaber HD; Gawellek F; Singer P
    Dtsch Gesundheitsw; 1968 Oct; 23(43):2017-24. PubMed ID: 5732807
    [No Abstract]   [Full Text] [Related]  

  • 46. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension.
    Fagard RH; Stolarz K; Kuznetsova T; Seidlerova J; Tikhonoff V; Grodzicki T; Nikitin Y; Filipovsky J; Peleska J; Casiglia E; Thijs L; Staessen JA; Kawecka-Jaszcz K
    J Hypertens; 2007 Nov; 25(11):2280-5. PubMed ID: 17921823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men.
    Hogarth AJ; Burns J; Mackintosh AF; Mary DA
    J Hum Hypertens; 2008 Aug; 22(8):544-9. PubMed ID: 18463670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
    Hahn RA; MacDonald BR; Martin MA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):206-14. PubMed ID: 6848744
    [No Abstract]   [Full Text] [Related]  

  • 50. [New viewpoints on the treatment of hypersensitivity. With comments on the pathogenesis of essential hypertension].
    Werning C
    Med Klin; 1974 Jun; 69(25):1087-99. PubMed ID: 4602392
    [No Abstract]   [Full Text] [Related]  

  • 51. Björn Folkow Award Lecture. The sympathetic nervous system in hypertension.
    Mancia G
    J Hypertens; 1997 Dec; 15(12 Pt 2):1553-65. PubMed ID: 9488206
    [No Abstract]   [Full Text] [Related]  

  • 52. Power spectral analysis of heart rate in elderly hypertensive subjects with or without silent coronary disease.
    Piccirillo G; Fimognari FL; Santagada E; Munizzi MR; Viola E; Monteforte G; Bucca C; Durante M; Di Gioacchino C; Tarantini S; Lo Verde A; Cacciafesta M; Marigliano V
    Angiology; 1996 Jan; 47(1):15-22. PubMed ID: 8546341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [How to treat effectively hypertensive patient with overactivity of sympathetic system?].
    Wańkowicz Z
    Pol Arch Med Wewn; 2002 Apr; 107(4):349-59. PubMed ID: 12189927
    [No Abstract]   [Full Text] [Related]  

  • 54. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder.
    Esler M; Eikelis N; Schlaich M; Lambert G; Alvarenga M; Kaye D; El-Osta A; Guo L; Barton D; Pier C; Brenchley C; Dawood T; Jennings G; Lambert E
    Ann N Y Acad Sci; 2008 Dec; 1148():338-48. PubMed ID: 19120127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.
    McGowan CL; Swiston JS; Notarius CF; Mak S; Morris BL; Picton PE; Granton JT; Floras JS
    Heart; 2009 May; 95(9):754-8. PubMed ID: 19151012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Does stress play a role in the pathogenesis of arterial hypertension and its complications?].
    Coca A; Bragulat E
    Med Clin (Barc); 1999 Oct; 113(11):411-2. PubMed ID: 10562952
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antihypertensive agents acting on the nervous system. 1. Physiology].
    Béroniade V
    Union Med Can; 1981 Nov; 110(11):962-6 contd. PubMed ID: 7324269
    [No Abstract]   [Full Text] [Related]  

  • 58. [Heart rate and heart rate variability: two parameters prognostic value of which merits further broadening].
    De Vecchis R; Pucciarelli A
    G Ital Cardiol (Rome); 2006 May; 7(5):371-2; author reply 372-3. PubMed ID: 16752522
    [No Abstract]   [Full Text] [Related]  

  • 59. Renin-angiotensin system in the brain as a new target of antihypertensive therapy.
    Ito S; Komatsu K; Yajima Y; Hirayama A
    Hypertens Res; 2008 Aug; 31(8):1487-8. PubMed ID: 18971519
    [No Abstract]   [Full Text] [Related]  

  • 60. [Imidazoline receptor agonists: are they actual today?].
    Nebieridze DV; Kamyshova TV
    Kardiologiia; 2012; 52(12):90-3. PubMed ID: 23237448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.